![Ross Leimberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ross Leimberg
Director-Operaciones de Back Office en Resilience Biotechnologies, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Steven Kelly | M | 59 |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | 6 años |
Deepa Pakianathan | M | 59 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 4 años |
David Johnson | M | 59 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 3 años |
Lee Styslinger | M | 63 |
Harvard Business School
| 12 años |
Rahul Singhvi | M | 59 |
Resilience Biotechnologies, Inc.
![]() Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | - |
Lynn Sharp Paine | M | 74 |
Harvard Business School
| 14 años |
Joseph Fuller | M | 67 |
Harvard Business School
| 12 años |
Sanford Zweifach | M | 68 |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | 3 años |
Regina Hodits | M | 53 |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | 6 años |
Briggs Morrison | M | 65 |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | 4 años |
Chidozie Ugwumba | M | 41 |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | 4 años |
Richard Morris | M | 51 |
CTx Operations, Inc.
![]() CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | 3 años |
Lori Hu | F | 38 |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 6 años |
Safa'a Al-Rais | M | - |
Resilience Biotechnologies, Inc.
![]() Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi. | - |
Denis Patrick | M | - |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | 3 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Miles K. Clements | M | - |
Harvard Business School
| 2 años |
Elizabeth Brillman | F | - |
Harvard Business School
| 2 años |
Maurice Taylor | M | 38 |
Harvard Business School
| 4 años |
Momie Qu | F | - |
Harvard Business School
| 2 años |
Ahmed El-Oraby | M | - |
Harvard Business School
| 2 años |
Gabe Turner | M | 42 |
Harvard Business School
| 2 años |
Konstantin von Bismarck | M | - |
Harvard Business School
| 3 años |
Brij Singh Khurana | M | - |
Harvard Business School
| 2 años |
Kyle Detwiler | M | 41 |
Harvard Business School
| 2 años |
Adam Besvinick | M | - |
Harvard Business School
| 2 años |
Alex Harding | M | - |
Harvard Business School
| 2 años |
Sorina Casian Botez | F | - |
Harvard Business School
| 2 años |
Eric Chernoff | M | - |
Harvard Business School
| 2 años |
Klaus Koenigshausen | M | - |
Harvard Business School
| 2 años |
Ali Najafbagy | M | - |
Harvard Business School
| 3 años |
Adam Hasiba | M | 40 |
Harvard Business School
| 2 años |
Megan Preiner | F | 40 |
Harvard Business School
| 2 años |
Lucy Zang | F | - |
Harvard Business School
| 2 años |
Jessica Kramer | F | - |
Harvard Business School
| 2 años |
Nick Birk | M | - |
Harvard Business School
| 2 años |
Toufic Khoueiry | M | - |
Harvard Business School
| 2 años |
Meredith Max Hodges | F | 43 |
Harvard Business School
| 2 años |
Rohan Ranavat | M | - |
Harvard Business School
| 2 años |
Tyler Ellis | M | - |
Harvard Business School
| 2 años |
Tom Musgrave | M | - |
Harvard Business School
| 2 años |
mark younger | M | - |
Harvard Business School
| 3 años |
Allen Ruiz | M | - |
Harvard Business School
| 2 años |
Andrew Puschel | M | - |
Harvard Business School
| 2 años |
Rebecca Greene | F | - |
Harvard Business School
| 2 años |
Albert Wang | M | - |
Harvard Business School
| 2 años |
Katharine Nevins | F | - |
Harvard Business School
| 2 años |
Nate Kempner | M | - |
Harvard Business School
| 2 años |
Tara Reeves | F | 42 |
Harvard Business School
| 2 años |
William Bell | M | - |
Harvard Business School
| 2 años |
Jonathan Mandelbaum | M | - |
Accelerator Life Science Partners II LP
![]() Accelerator Life Science Partners II LP Investment ManagersFinance Part of Accelerator Services Corp, Accelerator Life Science Partners II LP functions as a venture capital fund. The company is based in Seattle, WA. | 5 años |
Nate Lowery | M | - |
Harvard Business School
| 2 años |
Pankaj Dinodia | M | 39 |
Harvard Business School
| 2 años |
Jonathan Enav | M | - |
Harvard Business School
| 2 años |
Andrew Boston | M | - |
Harvard Business School
| 2 años |
Scott Hofmeister | M | - |
Harvard Business School
| 2 años |
Melike Abacioglu | F | - |
Harvard Business School
| 2 años |
Matthew W. Nugent | M | - |
Harvard Business School
| 2 años |
Louis Beryl | M | - |
Harvard Business School
| 2 años |
Arvind Navaratnam | M | - |
Harvard Business School
| 2 años |
Parminder Singh | M | - |
Harvard Business School
| 2 años |
Erin Arnold | F | - |
Harvard Business School
| 2 años |
Martha Osier | F | - |
Harvard Business School
| 2 años |
Rafael E. Romero | M | - |
Harvard Business School
| 2 años |
Rachel D. Jonas | F | - |
Harvard Business School
| 2 años |
Patricia Bellinger | F | 63 |
Harvard Business School
| 2 años |
Melvin Hibberd | M | - |
Harvard Business School
| 2 años |
Alexander Appel | M | - |
Harvard Business School
| 2 años |
Eduardo G. Arguello | M | - |
Harvard Business School
| 2 años |
Tyler D. Gordon | M | - |
Harvard Business School
| 2 años |
Marques Torbert | M | - |
Harvard Business School
| 2 años |
Cindy Cheung | F | - |
Harvard Business School
| 2 años |
Christopher John Kirubi | M | 82 |
Harvard Business School
| - |
Ruoxi Chen | M | 40 |
Harvard Business School
| 2 años |
Jonathan Nuger | M | - |
Harvard Business School
| 2 años |
Shiyan Koh | F | - |
Harvard Business School
| 2 años |
Anthony Ling | M | - |
Harvard Business School
| 2 años |
Philip Giampietro | M | - |
Harvard Business School
| 2 años |
Aymeric Chaumet | M | - |
Harvard Business School
| 4 años |
Benjamin Leahy Marshall | M | 40 |
Harvard Business School
| 2 años |
Howard Allan Scott | M | - |
Harvard Business School
| 2 años |
Emre Demirel | M | - |
Harvard Business School
| 2 años |
Adam Enbar | M | - |
Harvard Business School
| 2 años |
T. T. Nguyen Duc | F | - |
Harvard Business School
| 2 años |
Onusa Chantanapongwanij | M | - |
Harvard Business School
| 2 años |
Jean Ann Salisbury | F | - |
Harvard Business School
| 2 años |
Christos Brozos | M | - |
Harvard Business School
| 3 años |
Lawrence Jeremy Sadaka | M | - |
Harvard Business School
| 2 años |
Kevin Y. Hwang | M | - |
Harvard Business School
| 2 años |
Chris Kirk | M | - |
Harvard Business School
| 4 años |
Matthew Scholder | M | - |
Harvard Business School
| 2 años |
Matthew Salzberg | M | 40 |
Harvard Business School
| 2 años |
Magnus Grufman | M | - |
Harvard Business School
| 2 años |
Chingiz Gadimov | M | - |
Harvard Business School
| 2 años |
Roy Ben-Dor | M | 41 |
Harvard Business School
| 4 años |
Peter Saldarriaga | M | 41 |
Harvard Business School
| 2 años |
Ben D. Levy | M | - |
Harvard Business School
| 2 años |
Hans Reuter | M | - |
Harvard Business School
| 2 años |
Brandon Farwell | M | - |
Harvard Business School
| 2 años |
Aneal Krishnan | M | - |
Harvard Business School
| 2 años |
Chelsea Burkett | F | - |
Harvard Business School
| 2 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 98 | 98.00% |
Canadá | 2 | 2.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Ross Leimberg
- Red Personal